Tomivosertib

未知生产厂商

Tomivosertib is under investigation in clinical trial NCT03318562 (A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Tomivosertib is under investigation in clinical trial NCT03318562 (A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。